Study the level of sputum matrix metalloproteinase-9 and tissue inhibitor metaloprotienase-1 in patients with interstitial lung diseases
Background: Pulmonary fibrosis, the final result of a large variety of interstitial lung diseases, is characterized by an aberrant remodeling of extracellular matrix (ECM) with a profound disturbance of the normal lung architecture. This remodeling includes the exaggerated accumulation of ECM compon...
Main Authors: | Sherif A. Esa, Abeer M. Rawy, Mona M. El-Behissy, Mahmoud El-Bastawisy |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
Series: | Egyptian Journal of Chest Disease and Tuberculosis |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0422763815300698 |
Similar Items
-
Study of the level of sputum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor metalloproteinase-1 (TIMP-1) in COPD patients
by: Sherif A. Esa, et al.
Published: (2014-10-01) -
Interplay between matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in acute asthma exacerbation and airway remodeling
by: Ghada Mahmoud Mohamed, et al.
Published: (2012-07-01) -
Roles of Matrix Metalloproteinases and Their Natural Inhibitors in Prostate Cancer Progression
by: Yixuan Gong, et al.
Published: (2014-06-01) -
Expression of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Endometriosis Menstrual Blood
by: Tita Husnitawati Madjid, et al.
Published: (2020-06-01) -
Matrix Metalloproteinases MMP-2 and MMP-9, Their Inhibitors TIMP-1 and TIMP-2, Vascular Endothelial Growth Factor and sVEGFR-2 as Predictive Markers of Ischemic Retinopathy in Patients with Systemic Sclerosis—Case Series Report
by: Arleta Waszczykowska, et al.
Published: (2020-11-01)